Full Text
The Full Text of this article is available as a PDF (65.2 KB).
. 2006 Jun 7;9(4):389–395. doi: 10.1111/j.1527-3458.2003.tb00262.x
CNS FORUM Advancements in Clinical Trials and Drug Development Philadelphia, PA, USA, July 29–30, 2003
Alexander Scriabine
1,✉
Alexander Scriabine
1Department of Pharmacology, Yale University School of Medicine, New Haven CT, USA
Find articles by Alexander Scriabine
1Department of Pharmacology, Yale University School of Medicine, New Haven CT, USA
*
Address correspondence and reprint requests to: A. Scriabine, M.D., Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Tel.: +1 (203) 453–1800; Fax: +1 (203) 458–8428; E‐mail: alexander.scriabine@snet.net
✉
Corresponding author.
Issue date 2003 Dec.
Keywords: Clinical trials, CNS drugs, Cognition, Neuropathic pain, Pramipexole, Rotigotine, Schizophrenia
PMCID: PMC6494158